Tag Archives: AERI

Thursday’s Midday Stock Update: Celldex (CLDX), Inovio Pharmaceuticals (INO), Brainstorm Cell Therapeutics (BCLI), Aerie Pharma (AERI), Nu Skin (NUS)

So far Thursday, July 2, NASDAQ is down -0.04% and the S&P is down -0.1%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Celldex (CLDX – Research Report), Inovio Pharmaceuticals (INO – Research

Aerie Pharma (AERI) Gets a Buy Rating from Needham

In a report issued on June 5, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report), with a price target of $38.00. The company’s shares closed last Friday at $15.06. According to TipRanks.com, Belanger

A Director at Aerie Pharma is Exercising Options

Yesterday it was reported that a Director at Aerie Pharma (AERI – Research Report), Murray Goldberg, exercised options to buy 28,000 AERI shares at $3.15 a share, for a total transaction value of $88.2K. This recent transaction increases Murray Goldberg’s

A Director at Aerie Pharma (NASDAQ: AERI) is Selling Shares

Yesterday, a Director at Aerie Pharma (AERI – Research Report), Gerald Cagle, sold shares of AERI for $76.35K. This is Cagle’s first Sell trade following 7 Buy transactions. See today’s analyst top recommended stocks >> Based on Aerie Pharma’s latest

Analysts’ Top Healthcare Picks: Aerie Pharma (AERI), Atara Biotherapeutics (ATRA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI – Research Report) and Atara Biotherapeutics (ATRA – Research Report) with bullish sentiments. Aerie Pharma (AERI) In a report

Needham Thinks Aerie Pharma’s Stock is Going to Recover

Needham analyst Serge Belanger assigned a Buy rating to Aerie Pharma (AERI – Research Report) today and set a price target of $40.00. The company’s shares closed last Thursday at $14.01, close to its 52-week low of $10.81. According to